The expression of phosphatidylserine-specific phospholipase A 1 (PS-PLA 1 ) is most upregulated in the genes of peripheral blood cells from chronic rejection model rats bearing long-term surviving cardiac allografts. The expression profile of PS-PLA 1 in peripheral blood cells responsible for the immune response may indicate a possible biological marker for rejection episodes. In this study, PS-PLA 1 mRNA expression was examined in human THP-1-derived macrophages. The effects of several immunosuppressive agents on this expression were also examined in in vitro experiments. A real-time RT-PCR analysis revealed that PS-PLA 1 mRNA expression was found in human THP-1-derived macrophages. This expression was enhanced in the cells stimulated with lipopolysaccharide (LPS), a toll-like receptor (TLR) 4 ligand. Other TLR ligands (TLR2, 3, 5, 7, and 9) did not show a significant induction of PS-PLA 1 mRNA. The time course of the mRNA expression profiles was different between PS-PLA 1 and tumor necrosis factor-α (TNF-α), which showed a maximal expression at 12 and 1 h after LPS stimulation, respectively. Among the observed immunosuppressive agents, corticosteroids, prednisolone, 6α-methylprednisolone, dexamethasone, and beclomethasone inhibited PS-PLA 1 expression with half-maximal inhibitory concentrations less than 3.0 nM, while methotrexate, cyclosporine A, tacrolimus, 6-mercaptopurine, and mycophenoic acid showed either a weak or moderate inhibition. These results suggest that the expression of PS-PLA 1 mRNA in THP-1-derived macrophages is activated via TLR4 and it is inhibited by corticosteroids, which are used at high dosages to suppress chronic allograft rejection. 759 760 HOSONO ET AL.
INTRODUCTION
PS-PLA 1 , an enzyme of the lipase family, acts specifically on phosphatidylserine (PS) and hydrolyzes fatty acid from the sn-1 position of PS to produce lysophos-The control of chronic rejection is important for longterm graft survival in organ transplantation, because this phatidylserine (lysoPS) and fatty acid (6,7, 16, 20, 24) . Because both PS and lysoPS are associated with the acti-is a significant cause of graft loss during the first year following transplantation (11) . Therefore, specific and vation of immune cells, including macrophages via PS and lysoPS receptors (15, 18, 19, 21) , the activity of PS-sensitive markers predicting the chronic rejection are required for improving the clinical outcome. The current PLA 1 might be important for the immune response in regulating the production or elimination of PS and study used a high-throughput microarray analysis to demonstrate that phosphatidylserine-specific phospholi-lysoPS (1,2). A marked elevation of the PS-PLA 1 expression is observed in rats treated with lipopolysaccha-pase A 1 (PS-PLA 1 ) showed the highest upregulated expression among all the observed genes in peripheral ride (LPS) (4), thus suggesting that PS-PLA 1 plays a role in the activated immune system (1), which is associated blood cells from chronic rejection model rats with longterm surviving cardiac allografts (12) .
with chronic rejection (11) . The current study focused on the expression profile of PS-PLA 1 in immune cells polyinosine-polycytidylic acid [poly(I:C)], flagellin (from B. subtilis), loxoribine and oligonucleotide 2006 (ODN2006) as sample specimens for clinical application.
This study examined PS-PLA 1 mRNA expression in were purchased from InvivoGen (San Diego, CA) and prepared according to the manufacturer's instructions. human THP-1-derived macrophages stimulated by tolllike receptor (TLR) ligands, including LPS. The effects RPMI-1640 medium, dimethyl sulfoxide (DMSO), prednisolone (PSL), 6α-methylprednisolone (MPSL), 6-of immunosuppressive agents on the expression were also examined using this in vitro system. mercaptopurine monohydrate (6MP), tacrolimus (TAC), dexamethasone (DEX), and mycophenoic acid (MPA) MATERIALS AND METHODS were purchased from Sigma-Aldrich (St. Louis, MO).
Materials and Reagent Solutions
Beclomethasone dipropionate (BDP) was purchased from MP Biomedicals (Solon, OH). Methotrexate LPS (ultra-pure lipopolysaccharide, from Escherichia coli K12), heat-killed Listeria monocytogenes (HKLM), (MTX), cyclosporine A (CYA), and phorbol 12-myris- (Stratagene). The expression levels of mRNA for each gene were normalized by that of GUS.
All data are presented as the mean ± SD. Nonretate 13-acetate (PMA) were purchased from Wako peated measures ANOVA followed by Dunnett's test Chemicals (Osaka, Japan). Fetal bovine serum (FBS) was used to assess any significant differences between was purchased from JRH Biosciences (Lenexa, KS). All the absolute values. Significance was set at p < 0.05. other reagents and solvents for the assay were of either analytical or regent grade and they were purchased from RESULTS Wako Chemicals or Sigma-Aldrich.
PS-PLA 1 mRNA Expression in Human THP-1-Derived Macrophages Cell Culture
The THP-1 human monocytic cell line (ATCC, TIB-The PS-PLA 1 mRNA expression was compared with the expression of TNF-α mRNA (positive control for 202) was maintained in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, 2 mM L-gluta-TLR response) in the THP-1-derived macrophages after treating the cells with several TLR ligands for 1 and mine, 100 U/ml penicillin, 100 µg/ml streptomycin at 37°C in 5% CO 2 . Differentiated THP-1 cells were ob-12 h. Among the TLR ligands [HKLM, poly(I:C), LPS, flagellin, loxoribine, and ODN2006 for TLR2, TLR3, tained by treatment with 5 nM PMA for 2 days and then were starved overnight in RPMI-1640 medium containing TLR4, TLR5, TLR7, and TLR9, respectively], LPS induced PS-PLA 1 expression at 12 h after treatment, while 0.5% FBS and 5 nM PMA. They were thereafter stimulated with 0-10 −5 g/ml LPS in the presence of 10% heat-no other ligands exhibited such induction (data not shown). On the other hand, TNF-α mRNA was induced inactivated FBS for up to 34 h. In some experiments, differentiated THP-1 cells were stimulated with HKLM (10 8 when the cells were treated with HKLM, LPS, and flagellin for 1 h (data not shown). cells/ml), poly(I:C) (25 mg/ml), flagellin (10 −5 g/ml), loxoribine (1 mM), or ODN2006 (5 mM) instead of LPS. To LPS treatment increased PS-PLA 1 mRNA expression on THP-1-derived macrophages 800-fold, which was investigate the effects of immunosuppressants, cells were treated with 10 −5 M of PSL, MPSL, DEX, BDP, MTX, four times greater than that of cPLA 2 α (Fig. 1) . The upregulation of PS-PLA 1 mRNA was LPS dose depen-6MP, CYA, or TAC together with/without LPS (10 −5 g/ ml) for 12 h. Dose dependency was also examined in dent at the concentration of 10 −9 -10 −5 g/ml (data not shown). The time course profiles of mRNA expression 10 −9 -10 −4 M of PSL, MPSL, DEX, and BDP.
after LPS stimulation was different between PS-PLA 1 Quantitative Real-Time RT-PCR Analysis and TNF-α. The maximum mRNA expression for PS-PLA 1 and TNF-α was at 12 and 1 h after LPS stimula-Primer sets used were synthesized at Invitrogen (Carlsbad, CA). The primer sets were: PS-PLA 1 (sense, 5′-tion, respectively (Fig. 1) . Effects of Immunosuppressive Agents on PS-PLA 1 nitude of the inhibitory effects for PS-PLA 1 mRNA expression was almost the same as those for cPLA 2 α mRNA Expression (Fig. 2) . This means that corticosteroids may exert dif-Among the immunosuppressive agents, corticosteferent immunosuppressive effects on the status of PSroids (PSL, MPSL, DEX, and BDP) showed marked in-PLA 1 expression via TLR4 activation. High-dose cortihibition of PS-PLA 1 mRNA expression, while other costeroids for chronic rejection (8) may therefore be a agents, MTX, CYA, TAC, 6MP and MPA, showed reasonable therapeutic strategy if PS-PLA 1 plays an imweak or little effects (Table 1 ). The inhibitory effects of portant role. Further study is thus required to confirm corticosteroids on PS-PLA 1 mRNA expression were this speculation. dose dependent (Fig. 2) . The half-maximal inhibitory
In conclusion, PS-PLA 1 mRNA was specifically exconcentration (IC 50 ) for PSL was 3.0 nM (Fig. 2) . The pressed via TLR4 activation in THP-1-derived macroinhibitory effects of corticosteroids on mRNA expresphages. This expression was inhibited by corticostesion for cPLA 2 α were similar to those for PS-PLA 1 (Fig. roids, but not by other immunosuppressive agents. The 2). Other agents inhibited cPLA 2 α mRNA expression, clinical application of this potential treatment modality although the inhibitory effects were weaker than that for in allograft immunity therefore requires further investicorticosteroids (Table 1) .
gation. DISCUSSION
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vated by treating the cells with LPS, a typical TLR4 ligand, but not with other TLR ligands. The induction REFERENCES of PS-PLA 1 is also observed in rats after the administration of LPS (4). These findings suggest that PS-PLA 1
